Hepatitis b patients under the microscope: new study observes Real-World treatments
NCT ID NCT03692897
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study observed over 1,700 adults with chronic hepatitis B in the US and Canada to understand how the disease progresses and how treatments are used in everyday medical practice. Researchers collected data from both academic and community clinics to build a real-world picture of patient care. The study did not test any new drug or intervention, but aimed to improve knowledge about managing hepatitis B.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELTA HEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asian Pacific Liver Center at Coalition of Inclusive Medicine
Los Angeles, California, 90020, United States
-
Atlanta Gastroenterology
Atlanta, Georgia, 30342, United States
-
Banner University Medical Center Phoenix
Phoenix, Arizona, 85006, United States
-
Bon Secours Liver Institute of Richmond
Richmond, Virginia, 23226, United States
-
California Liver Research Institute
Pasadena, California, 91105, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Consultative Gastroenterology
Atlanta, Georgia, 30308, United States
-
Digestive and Liver Disease Specialist
Norfolk, Virginia, 23502, United States
-
Dreamwork Medical, PLLC
Flushing, New York, 11354, United States
-
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Mercy Medical Center
Baltimore, Maryland, 21202, United States
-
Minnesota Gastroenterology, P.A.
Plymouth, Minnesota, 55446, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Northwell Health Center for Liver Diseases and Transplantation
Manhasset, New York, 11030, United States
-
Rush Universtiy Medical Center
Chicago, Illinois, 60612, United States
-
Rutgers, Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
-
Silicon Valley Research Institute
San Jose, California, 95128, United States
-
Stanford University
Redwood City, California, 94063, United States
-
Swedish Organ Transplant and Liver Center
Seattle, Washington, 98104, United States
-
UC Davis GI/Hepatology Clinical Trials Unit
Sacramento, California, 95817, United States
-
UHN Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
-
UNC Liver Center
Chapel Hill, North Carolina, 27599, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Florida
Gainesville, Florida, 32610-0272, United States
-
University of Miami, Schiff Center for Liver Disease
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Washington/Harborview Medical Center
Seattle, Washington, 98104, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
-
Weill Cornell Medical College
New York, New York, 10021, United States
-
Yale University Digestive Diseases
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app tame Alcohol-Related liver disease?
- Can a smarter scan make liver testing more reliable?
- Can a targeted antibody stop severe hepatitis from destroying Children's livers?
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a quick MRI scan reveal what a healthy Child's liver looks like?
- Can a simple roadside test catch liver disease before it turns deadly?